In addition, it addresses the FDA’s communications With all the applicant, the retention of data that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report to a different applicant and electronic submission of the SE report and ame